HK$53.20+HK$0.25 (+0.47%)
Shanghai HeartCare Medical Technology Corporation Limited’s quoted price sits in the upper half of its reported 52-week range, 20.48% below the high.
Loading market information…
HKSE · 2453.HK · HKD
Stock price
Quote as of Oct 30, 2026, 08:08 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Concord Healthcare Grp Co Ltd’s quoted price sits in the lower half of its reported 52-week range, 76.77% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Concord Healthcare Group Co., Ltd. is dedicated to providing comprehensive cancer treatment services for patients and healthcare institutions throughout China. Its operations extend beyond direct care to include the distribution and installation of medical hardware and software, along with offering management and technical assistance, and providing equipment via operating leases. The company was founded in 2008 and is headquartered in Beijing, China. It functions as a subsidiary of Shanghai Medstar Financial Leasing Company.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:25 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$53.20+HK$0.25 (+0.47%)
Shanghai HeartCare Medical Technology Corporation Limited’s quoted price sits in the upper half of its reported 52-week range, 20.48% below the high.
HK$2.36HK$0.00 (0.0%)
Chaoju Eye Care Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 24.84% below the high.
HK$3.10-HK$0.01 (-0.32%)
HighTide Therapeutics Inc’s quoted price sits in the lower half of its reported 52-week range, 34.32% below the high.
HK$0.93-HK$0.01 (-0.54%)
Rici Healthcare Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 25.4% below the high.
HK$0.90+HK$0.03 (+2.87%)
PW Medtech Group Limited’s quoted price sits in the lower half of its reported 52-week range, 41.12% below the high.
HK$0.16HK$0.00 (0.0%)
Town Health International Medical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 44.41% below the high.
HK$0.85-HK$0.03 (-2.86%)
C-MER Medical Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 54.05% below the high.
HK$1.33-HK$0.12 (-8.28%)
Sipai Health Technology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 56.11% below the high.
